These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. New questions regarding bioequivalence of levothyroxine preparations: a clinician's response. Green WL AAPS J; 2005 Mar; 7(1):E54-8. PubMed ID: 16146330 [TBL] [Abstract][Full Text] [Related]
6. Comparative bioequivalence study of a new levothyroxine solution versus a reference L-thyroxine solution in normal healthy volunteers. Chassard D; Kerihuel JC; Caplain H; Tran Quang N; Thebault JJ Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():324-6. PubMed ID: 1820903 [TBL] [Abstract][Full Text] [Related]
7. Levothyroxine dosage and the limitations of current bioequivalence standards. Hennessey JV Nat Clin Pract Endocrinol Metab; 2006 Sep; 2(9):474-5. PubMed ID: 16957756 [No Abstract] [Full Text] [Related]
8. Bioequivalence of generic preparations of levothyroxine. Toft A Clin Endocrinol (Oxf); 2009 Oct; 71(4):603; author reply 603-4. PubMed ID: 19508682 [No Abstract] [Full Text] [Related]
9. Levothyroxine: therapeutic use and regulatory issues related to bioequivalence. Wartofsky L Expert Opin Pharmacother; 2002 Jun; 3(6):727-32. PubMed ID: 12036412 [TBL] [Abstract][Full Text] [Related]
10. Bioequivalence studies for levothyroxine. Bolton S AAPS J; 2005 Mar; 7(1):E47-53. PubMed ID: 16146349 [TBL] [Abstract][Full Text] [Related]
11. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340 [TBL] [Abstract][Full Text] [Related]
12. Bioequivalence of levothyroxine preparations for treatment of hypothyroidism. Spigelman MK JAMA; 1997 Apr; 277(15):1199-200. PubMed ID: 9103337 [No Abstract] [Full Text] [Related]
13. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study. Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789 [TBL] [Abstract][Full Text] [Related]
14. Are multisource levothyroxine sodium tablets marketed in Egypt interchangeable? Abou-Taleb BA; Bondok M; Nounou MI; Khalafallah N; Khalil S Ann Endocrinol (Paris); 2018 Feb; 79(1):23-29. PubMed ID: 29289332 [TBL] [Abstract][Full Text] [Related]
15. Levothyroxine sodium tablets: chemical equivalence and bioequivalence. Curry SH; Gums JG; Williams LL; Curry RW; Wolfson BB Drug Intell Clin Pharm; 1988; 22(7-8):589-91. PubMed ID: 3046889 [TBL] [Abstract][Full Text] [Related]
16. Bioequivalence of levothyroxine preparations: industry sponsorship and academic freedom. Eckert CH JAMA; 1997 Apr; 277(15):1200-1. PubMed ID: 9103338 [No Abstract] [Full Text] [Related]
20. [Bioequivalence of L-thyroxine tablets and a liquid L-thyroxine solution in the treatment of hypothyroid patients]. Grussendorf M; Vaupel R; Wegscheider K Med Klin (Munich); 2004 Nov; 99(11):639-44. PubMed ID: 15583873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]